Komori
Premier Anti-Aging (4934) · RiskMaterialised

Impairment losses on investments and receivables due to the Chinese sales subsidiary's failure to achieve its business plan

First written in FY2022. 5 of 9 entries say "Materialised", first in FY2022. Latest entry: FY2026.

9entries
5years
6from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseWorsenedFY2022 – 2026-07-142022: 120222023: 120232024: 020242025: 020252026: 72026
Same theme, other companies
Risk of Recovery Shortfalls and Valuation Losses on Loans to and Investments in AffiliatesA theme 49 companies write about · 51 as a headwind · 0 as a tailwind

Premier Anti-Aging moved to the "Worse" side of this theme in 2022, the same year as the typical company in this theme.

The whole theme swung hardest in 2019: 7 of 15 companies on the "Worse" side.

18 other companies' latest entry also says "Materialised".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 49 companies compared. The sentences above are computed from all 49.
Full recordFilings, disclosures and news, newest first
  1. FY2026MaterialisedAnnual report

    「We decided to consolidate our sales structure in China into efficient, high-growth cross-border e-commerce, dissolve and liquidate the local subsidiary, and record ¥206 million in business restructuring costs associated with this as an extraordinary loss.」

    Issues with the China business plan and sales structure materialized as the dissolution and liquidation of the local subsidiary and ¥206 million in business restructuring costs. Bei An Mei (Shanghai) had negative net worth of ¥1,121 million at the end of July 2026.
  2. FY2023WorsenedAnnual report

    「Provision for doubtful accounts of ¥713,592 thousand」

    The company recorded a ¥713.592 million provision for doubtful accounts on receivables from affiliates, including its Chinese sales subsidiaries, and the allowance balance increased to ¥1,288.324 million. As in the previous fiscal year, the deterioration in the valuation of investments and receivables due to the Chinese business falling short of plan continued to progress.
  3. FY2022MaterialisedAnnual report

    「As a result of our review, we determined that the investment in ベイ安美(上海)化粧品有限公司 was not expected to recover to its acquisition cost based on future business plans, and therefore recorded an impairment loss on investments in an affiliated company of ¥520,859 thousand in the current fiscal year. In addition, we determined that ¥633,432 thousand of the receivables from ベイ安美(上海)化粧品有限公司 were uncollectible and recorded an allowance for doubtful accounts.」

    For the Chinese sales subsidiary, a decline in the recoverability of the investment and uncollectibility of receivables actually occurred, resulting in an impairment loss on the investment of ¥520,859 thousand and an allowance for doubtful accounts of ¥633,432 thousand.
Moved together

"Expansion of Overseas Sales Markets, Primarily in Asia" moved the same way as this thread, in the same document, in 8 of its 9 moves.

866333★123456
  1. ★This thread
  2. 1Expansion of Overseas Sales Markets, Primarily in Asia8×
  3. 2Revenue growth and improved profitability6×
  4. 3Improving Profit Margins and Stabilizing Sales6×
  5. 4Acquiring New Customers and Strengthening CRM for Existing and Dormant Customers3×
  6. 5Dependence on Interest-Bearing Debt and Financing Constraints3×
  7. 6Achieving profitability in the fiscal year ending July 2024 and an operating margin of 10% or more in the fiscal year ending July 2027 through structural reform3×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Premier Anti-Aging yet. It last moved in the General Meetings of Shareholders of 2026-10-02: "Worsened".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Impairment losses on investments and receivables due to the Chinese sales subsidiary's failure to achieve its business plan | Premier Anti-Aging Co.,Ltd. (4934) | Komori